ABSTRACT Terbutaline sulphate (0*25 mg) was given intravenously to 10 recumbentpatients with severe irreversible airflow obstruction and pulmonary hypertension who were undergoing right heart catheterisation. Alveolar ventilation index, cardiac index, and mean pulmonary artery pressure all rose significantly at 5 minutes and then fell by 35 minutes, although the first two remained higher than control levels. This was accompanied by a small but significant rise in arterial oxygen tension at 5 minutes. There were no significant changes in ventilation-perfusion relationships at either 5 or 35 minutes.
the drug and pulmonary and systemic vasodilatation produced by thef2 activity,7-9 both effects resulting in an increase in intrapulmonary shuntingandvenousadmixture. This may be partially offset in patients with reversible airflow obstruction by bronchodilatation and increased alveolar ventilation. [1] [2] [3] [4] Patients with severe fixed airflow obstruction and pulmonary hypertension, however, may not respond in a similar way and may be at greater risk ofdevelopingfurtherhypoxaemiaaftertreatment.
Terbutaline is less likely to cause increased hypaxaemia because it is a relatively selective,82-adrenergic agonist, 10-12 having little 13, effect on cardiac output and hence on the pulmonary circulation,'3-'6 although a reduction in arterial oxygen tension (Pao2) does occur in some patients when it is given by the parenteral routes. "7- 18 Stockley et al'9 showed a small but significant increase in venous admixture in patients with chronic bronchitis and pulmonary hypertension 40 minutes after an intravenous dose of terbutaline, without a fall in arterial oxygen tension. The doses ofterbutaline, however, were small. Using a larger intravenous dose, Teule et al '7 found no significant change in venous admixture, but Add-ess for reprint requests: Dr RA Stockley, General Hospital, Steelhouse Lane, Birmingham B4 6NH. there was a slight fall in Pao2after 20 minutes in patient: with chronic obstructive bronchitis but without clinica cor pulmonale. Peak serum concentrations of terbuta line, however, occur about five minutes after an intra venous bolus20 and thus any effects on cardiopulmonar function should be maximal at this time and thereafte decline.
The purpose of the present study was to investigat the earlycardiopulmonarychanges occurringafteran ie travenous bolus ofterbutaline in a group ofpatients wit severe fixed airflow obstruction and pulmonary hype, tension. In particular, we were interested in anyadvers effect on ventilation-perfusion relationships and arteri, oxygen tension.
Methods
Ten patients (table) with chronic obstructive bro chitis were studied; none had any significant improv ment in airtlow obstruction following inhaled bronch dilators. All were hypoxaemic at rest and had e perienced at least one episode of cardiac failure wi oedema. The patients were being assessed for long-ter domiciliary oxygen treatment in accordance with t, criteria for the Medical Research Council trial and we studied in a stable clinical state at least six weeks aP any episode of cardiac failure or respiratory infecti. Some were receiving digoxin and all were taking diS tics. Bronchodilator and oxygen treatment were disi tinued at least 24 hours before investigation. All pati, gave informed consent to the catheterisation as p7 the protocol of the MRC trial. All were informed c nature of the additional drug study and told tht wished to monitor the effect ofterbutaline on the cq Pulmonary function was measured by conventional techniques.'9 All patients underwent right heart catheterisation and were studied supine and fasting. After 30 minutes' rest arterial gas tensions were measured; expired gases were collected, measured, and analysed for oxygen and carbon dioxide content; and heart rate and intravascular pressures were recorded.
After this, terbutaline (250 pg) was injected into the pulmonary artery over 30-45 seconds without the patients' knowledge and ventilatory measurements were repeated after 31/2-6½/2 minutes, blood samples being taken at 5 minutes. All measurements were repeated 35 minutes after the drug had been given.
Cardiac output, pulmonary vascular resistance, and intravascular pressures were measuredand calculated as previously described. 19 Total systemic vascular resistance was taken as the mean brachial arterypressure divided by the cardiac output. Calculation of tidal volume (VT), respiratory rate, and ventilation was made from the expiratory trace recorded on a Tissot spirometer. Physiological dead space (VD) and the ratio with tidal volume (VD/VT) were calculated from the Bohr equation and the respiratory exchange ratio. Venous admixture (QS/QT) and the alveolar arterial oxygen difference (A-aDo2) were calculated from the shunt equation, the ideal alveolar oxygen tension being obtained from the alveolar gas equation. Alveolar ventilation was calculated as the difference between overall and deadspace ventilation. Oxygen uptake rose from 218-5 (SE + 14-7) ml/min to 247-6 (SE ± 15-2) ml/min at 5 minutes and remained raised at 240-9 (SE + 11 7) ml/min at 35 minutes. Similarly, carbon dioxide production increased from a mean control level of 1619 (SE + 11 8) ml/min to 210-8 (SE + 15-7) ml/min at 5 minutes, also remaining raised (186&2 (SE + 12-4) ml/min) at 35 minutes. This was accompanied by a fall in the arteriovenous oxygen difference from 6-0 (SE + 0 33) mm Hg (0-8 i 0 04 kPa) to 44 (SE ±O043) mm Hg(O-6+±006kPa)at5 minutes,with return to control levels at 35 minutes. Mixed venous blood saturation rose from a mean control level of56 5 (SE + 3 1) mm Hg (7 5 + 0-4 kPa) to 63-6 (SE + 37) mm Hg (8-5 + 0-5 kPa) at 5 minutes and remained raised at 62 3 (SE ± 2 77) mm Hg (8-3 ± 0 37 kPa) at 35 minutes.
Discussion
Halmagyi and Cotes4 suggested that agents affecting cardiac output and pulmonary vascular resistance may give rise to increased venous admixture, thereby reducingarterial oxygen tension in patients with chronic airflow obstruction, particularly if pulmonary hypertension is present. Terbutaline is one such agent but as its action is largely selective and directed to 2 receptors with a much less pronounced action on the heart'0-'6 it would be expected to have fewer adverse effects on ventilation-perfusion relationships. This assumption has been confirmed in both reversible9 16 and irreversible airflow obstruction, with'9 and without cor pulmonale.'7 Nevertheless, in several studies a small and unpredictable fall in Pao2 has been noted in some ofthe patients studied,9 17 18 although there are no studies relating to early cardiopulmonary changes when drug concentrations are at their highest.
In the present study no significant changes were noted in any ofthe indices ofventilation-perfusion inequality at either 5 minutes or 35 minutes after the drug was given, although the Pao2 rose initially in all but one patient. The maximum rise observed was in patient 2, from 57-9 mm Hg (7 7 kPa) to 72-5 mm Hg (9 64 kPa). The only patient (No 5) in whom the Pao2 fell had the highest resting Pao2 -77 0 mm Hg (10-24 kPa) -and least physiological impairment oflung function as well as the lowest resting venous admixture (12%) and mean pulmonary artery pressure (18 mm Hg). Although the 749 changes in Pao2 after bronchodilator drugs may be unpredictable,2' in the present study the patients with the lowest resting Pao2 and highest pulmonary vascular resistance all experienced atransient rise in Pao2. This suggests that there is only a small risk ofa dangerous fall in Pao2 even in the most severely affected patients.
The rise in Pao2 was unexpected but accompanied by an increase in alveolarventilation. Possibly this reflects a direct action ofterbutaline on chemoreceptors increasingventilatory drive, as similar changes have been noted for salbutamol,29 but further studies will be necessary to clarify this point. No changes were observed in Pco2 despite the increase in alveolarventilation. This may be explained by a rise in oxygen uptake and carbon dioxide production as a result ofthe increased ventilatory work, which may have partly offset the effect ofincreased ventilation on Paco2.
The increase in cardiac output, stroke volume, and heart rate at 5 minutes were expected and were associated with an appreciable fall in total systemic vascular resistance but no early change in mean brachial artery pressure. Later, at 35 minutes, the brachial artery pressure had fallen significantly and was accompanied by small reductions in both stroke index and cardiac index compared with the 5-minute value. The heart rate did not change from the 5-minute value but remained significantly raised. These early changes cannot be explained solely by a reflex response to systemicvasodilatation and hypotension, as has been suggested, 19 22 for two reasons. Firstly, no early fall in blood pressure was recorded and, secondly, all measurements were made in the supine position, where postural effects would be minimal."' Nevertheless, the blood pressure did fall at35 minutes in the presence ofa lower cardiac output but a sustained increase in heart rate, which is more typical of a predominant ,f2effect. The /3, effects ofterbutaline are dose related however, and thus the early changes, when drug concentrations are highest, are probably due to a combination of the ,1, effect on the heart and /2 peripheral vasodilation. Later, as serum concentrations decline, the ,effect is less prominent than the sustained B2action. This would explain the sustained tachycardia at 35 minutes, which is probably due largely to a reflex response to systemic hypotension and systemic vasodilatation (I82 effects). 13'14 The mean pulmonary artery pressure rose transiently with cardiac output and pulmonary vascular resistance fell. By 35 minutes the pulmonary artery pressure had returned to resting levels, although the cardiac output remained raised and pulmonary vascular resistance reduced. This may reflect changes in pulmonary vascular capacitance in response to the increased cardiac output rather than a direct 12 vasodilating effect of terbutaline on pulmonary resistance vessels,23 although either or both mechanisms may be operating.
In summary, terbutaline sulphate in the dose used had no major detrimental effects on gas exchange in the patients studied. The effects on the cardiovascular system were more noticeable at 5 minutes, when drug concentrations are likely to be at their highest, and suggest a combined ,f, and f2 response. It is concluded that terbutaline in this dose can be given to such patients without worsening their gas exchange and that it may even produce a temporary improvement. We would like to thank Miss J Downs for her typing and Mr BJ Milton for technical assistance. 
